Market closed: 9678.HK Unisound AI at HK$280.00 down 6.73% on 12 Mar 2026 : near-term model-driven outlook

The 9678.HK stock closed at HK$280.00 on 12 Mar 2026, down 6.73% after a HK$20.20 fall on heavier-than-normal trades. Unisound AI Technology Co Ltd. (9678.HK) listed on the HKSE saw 314,560 shares change hands, below its 50-day average. Investors reacted to profit-taking and weaker near-term momentum despite long-term AI demand. We examine valuation, technicals, Meyka AI modelling, and practical price targets to frame short and medium-term moves for Hong Kong investors.

9678.HK stock: Market snapshot and price drivers

Unisound AI Technology Co Ltd. (9678.HK) closed at HK$280.00, trading between HK$274.00 and HK$291.20 today. Volume reached 314,560 shares versus an average of 669,418. The company’s year high is HK$879.00 and year low is HK$198.00. Price fell after two sessions of profit-taking and a broader tech pullback in the Hong Kong Technology sector. Short-term selling pressure is visible, with relative volume at 0.47 and daily range near HK$17.20.

9678.HK stock: Fundamentals and valuation

Unisound (9678.HK) reports negative earnings per share of -7.90 and a trailing price-to-earnings ratio of -36.25, reflecting current losses. Market capitalisation stands at HK$20,323,215,507.00 with 70,960,948 shares outstanding. The IPO was on 30 Jun 2025 and the firm operates in Software – Infrastructure. Compared with Technology peers, Unisound trades below the sector average PEG and far below typical profitable peers. The company’s financial growth metrics require close monitoring as revenue mix shifts toward LLM commercialisation.

9678.HK stock: Technicals and trading levels

Technically, the stock sits below its 50-day average of HK$317.56 and well below the 200-day average of HK$488.38, signalling a medium-term downtrend. RSI is 43.52, MACD histogram is -1.45, and ADX is 18.46, indicating no strong trend. Bollinger middle band is HK$310.41 with lower band at HK$268.54, so current price is near the lower band. Support appears near the year low of HK$198.00 and initial resistance near HK$310.00.

Meyka AI rates 9678.HK with a score out of 100 and forecast

Meyka AI rates 9678.HK with a score out of 100 — 64.52 (Grade B, Suggestion: HOLD). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst inputs. Meyka AI’s forecast model projects a monthly price of HK$455.05, a quarterly level of HK$146.15, and a yearly projection of HK$42.13. Comparing the monthly projection to the current HK$280.00 implies an upside of 62.52%. Forecasts are model-based projections and not guarantees.

9678.HK stock: Risks and opportunities in AI sector

Unisound’s UniBrain platform aligns with fast-growing AI demand in smart life and healthcare. Sector tailwinds persist as Technology average net margin exceeds smaller peers. Key opportunities include commercial LLM contracts and vertical integration in healthcare. Principal risks are continued negative EPS, execution delays, and valuation compression versus profitable infrastructure peers. Liquidity is moderate with average volume 669,418, exposing the stock to larger intraday swings.

9678.HK stock: Analyst price targets and positioning

No consensus price target is published. A pragmatic three-scenario frame for Hong Kong investors: conservative target HK$220.00 (bear), base target HK$360.00 (near-term recovery), and bull target HK$520.00 (strong contract wins and margin improvement). These targets use multiples range-fitting to growth and peer comparisons and factor current EPS of -7.90 and revenue trajectory expectations.

Final Thoughts

Key takeaways for the 9678.HK stock on 12 Mar 2026: the share closed at HK$280.00, down 6.73%, with visible short-term selling and below-average liquidity. Fundamentals show a negative EPS of -7.90 and a trailing PE of -36.25, so valuation depends on earnings recovery. Meyka AI rates 9678.HK with a score out of 100 at 64.52 (Grade B, Suggestion: HOLD). Meyka AI’s forecast model projects a monthly price of HK$455.05, implying 62.52% upside versus today’s price, but the model also shows lower quarterly and yearly figures, highlighting scenario sensitivity. Investors should weigh growth upside from LLM commercialisation against execution risk, current negative earnings, and tight trading liquidity on the HKSE. For portfolio use, consider position sizing and stop-loss rules aligned with the stock’s volatility indicators. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.